Lexicon Pharmaceuticals Inc (LXRX) — Strategic Asset Allocation Index
Lexicon Pharmaceuticals Inc (LXRX) has a Strategic Asset Allocation Index of 1.2% as of June 2023. Strategic assets (PP&E of $2.20 Million plus long-term investments of $-) total $2.20 Million, measured against net assets of $186.36 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Lexicon Pharmaceuticals Inc Strategic Asset Allocation Index (2000–2022)
This chart shows how Lexicon Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 22 annual periods from 2000 to 2022. As of June 2023, the index stands at 1.2%, representing strategic assets of $2.20 Million against net assets of $186.36 Million USD. Explore Lexicon Pharmaceuticals Inc operating cash flow efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Lexicon Pharmaceuticals Inc (2000–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Lexicon Pharmaceuticals Inc from 2000 to 2022, covering 22 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Lexicon Pharmaceuticals Inc (LXRX) market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 1.8% | $2.07 Million | $2.07 Million | $- | $117.12 Million | ▲ +0.7 pp |
| 2021 | 1.0% | $1.18 Million | $1.18 Million | $- | $113.59 Million | ▲ +0.8 pp |
| 2020 | 0.2% | $295.00K | $295.00K | $- | $156.37 Million | ▼ -11.8 pp |
| 2019 | 12.0% | $14.05 Million | $14.05 Million | $- | $117.10 Million | ▼ -22.0 pp |
| 2017 | 33.9% | $17.69 Million | $17.69 Million | $- | $52.10 Million | ▲ +21.6 pp |
| 2016 | 12.3% | $19.39 Million | $19.39 Million | $- | $157.40 Million | ▲ +4.9 pp |
| 2015 | 7.4% | $21.23 Million | $21.23 Million | $- | $285.85 Million | ▲ +7.0 pp |
| 2014 | 0.4% | $1.08 Million | $1.08 Million | $- | $284.02 Million | ▼ -23.9 pp |
| 2013 | 24.3% | $41.36 Million | $41.36 Million | $- | $170.16 Million | ▲ +8.3 pp |
| 2012 | 16.0% | $42.63 Million | $42.63 Million | $- | $266.68 Million | ▲ +0.4 pp |
| 2011 | 15.6% | $46.42 Million | $46.42 Million | $- | $297.57 Million | ▼ -6.0 pp |
| 2010 | 21.6% | $53.43 Million | $53.43 Million | $- | $247.02 Million | ▼ -14.3 pp |
| 2009 | 35.9% | $58.75 Million | $58.75 Million | $- | $163.50 Million | ▲ +2.7 pp |
| 2008 | 33.2% | $65.09 Million | $65.09 Million | $- | $195.83 Million | ▲ +8.5 pp |
| 2007 | 24.7% | $70.83 Million | $70.83 Million | $- | $286.57 Million | ▼ -66.7 pp |
| 2006 | 91.5% | $78.19 Million | $78.19 Million | $- | $85.50 Million | ▼ -7.9 pp |
| 2005 | 99.4% | $85.27 Million | $85.27 Million | $- | $85.80 Million | ▲ +29.8 pp |
| 2004 | 69.6% | $84.57 Million | $84.57 Million | $- | $121.59 Million | ▲ +19.2 pp |
| 2003 | 50.3% | $83.68 Million | $83.68 Million | $- | $166.22 Million | ▲ +28.4 pp |
| 2002 | 22.0% | $37.36 Million | $37.36 Million | $- | $169.90 Million | ▲ +9.8 pp |
| 2001 | 12.2% | $26.71 Million | $26.71 Million | $- | $218.37 Million | ▲ +5.3 pp |
| 2000 | 7.0% | $14.48 Million | $14.48 Million | $- | $207.63 Million | — |